EN
HI
Summary
As of 30 Oct, 2026, Akums Drugs & Pharmaceuticals stock price is ₹731.7. During the trading session, the stock has moved between an intraday low of ₹722.75 and an intraday high of ₹755.00. Over the last 52 weeks, Akums Drugs & Pharmaceuticals has traded between ₹409.30 and ₹838.80.
The stock has recorded a trading volume of 1,45,381 shares,. Its Average Traded Price (ATP) is ₹732.59, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 34 @ ₹731.70.
Akums Drugs & Pharmaceuticals has an upper circuit limit of ₹815.15 and a lower circuit limit of ₹666.95. The total value traded stands at ₹10.65 CR, and the delivery percentage for the day is 56.86%.
The stock is currently traded with a market lot size of 1. Akums Drugs & Pharmaceuticals also offers a dividend yield of 0.4%.
Akums Drugs & Pharmaceuticals Share Price Chart
Akums Drugs & Pharmaceuticals Share Key Metrics
Volume
1.45 L
Market Cap
11516.52 CR
LTQ@LTP
34@731.70
ATP
732.59
Var Margin
17.57 %
Circuit Range
666.95-815.15
Delivery %
56.86 %
Value
10.65 CR
ASM/GSM
No
Market Lot
1
Akums Drugs & Pharmaceuticals Fundamentals
P/E Ratio
39.98
P/B Ratio
3.42
Div. Yield
0.4
Sector P/E
39.93
Sector P/B
3.3
Sec. Div. Yield
0.53
Akums Drugs & Pharmaceuticals Resistance and Support
Pivot 733.63
Resistance
First Resistance
752.41
Second Resistance
763.78
Third Resistance
782.56
Support
First Support
722.26
Second Support
703.48
Third Support
692.11
Akums Drugs & Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 30 2026 | 750 | 731.7 | -1.26% | 755 | 722.75 |
| Thu Oct 29 2026 | 717.59 | 741.04 | 2.54% | 745 | 714.84 |
| Wed Oct 28 2026 | 715 | 722.7 | 0.48% | 733 | 709.25 |
Akums Drugs & Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-02 | Quarterly Results |
| 2026-08-08 | Quarterly Results |
| 2026-05-14 | Audited Results & Final Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-02-06 | Quarterly Results |
| 2024-11-09 | Quarterly Results |
| 2024-08-24 | Quarterly Results |
Akums Drugs & Pharmaceuticals News
Akums Drugs and Pharmaceuticals Ltd - 544222 - Board Meeting Intimation for Intimation Of Board Meeting
Akums Drugs & Pharma board to meet on 02 Nov 2026 for financial results. The meeting will cover the quarter and half-year ended 30 Sep 2026.
Oct 28 2026 15:41:11
Akums Drugs and Pharmaceuticals Ltd - 544222 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Demand Notice
Akums Drugs' wholly-owned subsidiary, Pure & Cure Healthcare, received a demand notice of Rs.52.74 crore from NPPA for alleged overpricing of 'Lanol 1000 mg injection'. The company stated that under its supply agreement, the marketer, Hetero Healthcare, is solely liable for the penalty.
Oct 15 2026 16:38:57
Akums Drugs & Pharmaceuticals Management
| Name | Position |
|---|---|
| Sanjeev Jain | Managing Director |
| Sandeep Jain | Managing Director |
Akums Drugs & Pharmaceuticals Similar Stocks
CORONA Remedies Ltd.
2149.60
-67.80 (3.06%)
Concord Biotech Ltd.
1245.60
15.00 (1.22%)
Sudeep Pharma Ltd.
1068.30
-61.80 (5.47%)
Alivus Life Sciences Ltd.
1415.30
17.90 (1.28%)
Rainbow Children's Medicare Ltd.
1218.70
21.90 (1.83%)
Metropolis Healthcare Ltd.
545.65
-8.20 (1.48%)
Sanofi Consumer Healthcare India Ltd.
3442.30
-25.70 (0.74%)
Viyash Scientific Ltd.
218.39
-6.16 (2.74%)
Strides Pharma Science Ltd.
1068.80
-28.70 (2.62%)
Blue Jet Healthcare Ltd.
504.55
1.00 (0.20%)
Akums Drugs & Pharmaceuticals FAQs
The Buying Price of Akums Drugs & Pharmaceuticals share is 731.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Akums Drugs & Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Akums Drugs & Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Akums Drugs & Pharmaceuticals shares is 39.98. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Akums Drugs & Pharmaceuticals shares is 3.42. Useful to assess the stock's value relative to its book value.
To assess Akums Drugs & Pharmaceuticals’s valuation compare Sector P/E, P/B which are 39.93 & 3.3 with sector averages, along with growth rates and financial metrics.
The Market Cap of Akums Drugs & Pharmaceuticals is 11516.52 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Akums Drugs & Pharmaceuticals share price is 838.80 & 409.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Akums Drugs & Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in AKUMS
